VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML

NCT07635485 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hypoplastic Acute Myeloid Leukemia
Secondary AML (Adult)

Interventions

DRUG: Venetoclax (VEN)
DRUG: Azacitidine (AZA)
PROCEDURE: Allo-HSCT

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]